The anti–nectin-4 antibody-drug conjugate binds Nectin-4 on target cells, is internalized, and a cleavable linker releases a topoisomerase-1 inhibitor that blocks DNA replication, leading to cell-cycle arrest and apoptosis of Nectin-4–expressing cells.